145 related articles for article (PubMed ID: 36004532)
21. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
22. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
23. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
[TBL] [Abstract][Full Text] [Related]
24. Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine.
Mesholam-Gately RI; Gibson LE; Seidman LJ; Green AI
Schizophr Res; 2014 May; 155(1-3):45-51. PubMed ID: 24685823
[TBL] [Abstract][Full Text] [Related]
25. Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia.
Taipale H; Lähteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Schizophr Bull; 2021 Jan; 47(1):23-30. PubMed ID: 33428766
[TBL] [Abstract][Full Text] [Related]
26. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
27. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
29. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.
Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013
[TBL] [Abstract][Full Text] [Related]
31. Sudden unexplained death in schizophrenia patients: An autopsy-based comparative study from China.
Wang S; He M; Andersen J; Lin Y; Zhang M; Liu Z; Li L
Asian J Psychiatr; 2023 Jan; 79():103314. PubMed ID: 36399950
[TBL] [Abstract][Full Text] [Related]
32. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients.
Lähteenvuo M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Schizophr Res; 2021 Feb; 228():367-372. PubMed ID: 33548837
[TBL] [Abstract][Full Text] [Related]
34. Clozapine versus typical neuroleptic medication for schizophrenia.
Wahlbeck K; Cheine M; Essali MA
Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological treatment of violence in schizophrenia.
Strassnig MT; Nascimento V; Deckler E; Harvey PD
CNS Spectr; 2020 Apr; 25(2):207-215. PubMed ID: 31342892
[TBL] [Abstract][Full Text] [Related]
36. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis.
Solmi M; Taipale H; Holm M; Tanskanen A; Mittendorfer-Rutz E; Correll CU; Tiihonen J
Am J Psychiatry; 2022 Dec; 179(12):938-946. PubMed ID: 36200276
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
Velligan DI; Carroll C; Lage MJ; Fairman K
Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic utilisation and persistence in Australia: A nationwide 5-year study.
Taylor M; Dangelo-Kemp D; Liu D; Kisely S; Graham S; Hartmann J; Colman S
Aust N Z J Psychiatry; 2022 Sep; 56(9):1155-1163. PubMed ID: 34657454
[TBL] [Abstract][Full Text] [Related]
40. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
